Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence.  Lancaster K, Gendera S, Treloar C, Rhodes T, Shahbazi J, Byrne M, Nielsen S, Degenhardt L, Farrell M.  Int J Drug Policy. 2024 Feb 2…

Early Remission of Opioid Use Disorder in an Adolescent Using Buprenorphine Extended - Release Subcutaneous Injection: A Case Report.  Schmuhl KK, Golec A, Ebersole AM.  J Adolesc Health. 2024 Feb 24:S1054-139X(24)00050-8. doi: 10.1016/j…

Buprenorphine. Kumar R, Viswanath O, Saadabadi A., 2023 Nov 30.  In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29083570. https://www.ncbi.nlm.nih.gov/books/NBK459126/

Use of intravenous buprenorphine microdosing to initiate medication for opioid use disorder in a patient with co-occurring pain: case report, Alia Bodnar , Christine Diffenderffer , Lindsay A. Jablonski ,&nbs…

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.  Greenwald MK, Wiest KL, Haight BR, Laffont CM, Zhao Y.  Harm Reduct J. 2023 Dec 2;20(…

Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study.  Parkin S, Neale J, Strang J.  Int J Drug Policy. 2023 Dec;122:10422…